or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
brain tumour PhD Projects, Programmes & Scholarships
We have 32 brain tumour PhD Projects, Programmes & Scholarships
Cancer: Why and how do brain tumour cells invade ‘mini-brains’?
Globally, nearly 189,000 people die each year as a result of brain cancer and around 250,000 people are diagnosed with a malignant brain tumour (umbrella name. Read more
Developing a new therapeutic strategy for brain cancers: getting therapeutics directly to the tumour
Some brain cancers cannot be surgically removed, and many potent therapeutics cannot reach the tumour site. This project aims to overcome these hurdles by utilizing a recently developed multifunctional nanoparticle drug delivery system that can be injected directly into tumours. Read more
Identifying secreted biomarkers in brain cancer
Stage IV brain cancer or glioblastoma (GBM) poses a major challenge with only 5 FDA approved chemotherapeutic drugs available for treatment. Read more
(MRC DTP) Advanced MRI measurements for characterization and monitoring of brain tumours
We are seeking a highly motivated student with a strong background in physics or engineering and an interest in cancer physiology and neuroscience. Read more
(MRC DTP) Investigating brain plasticity in response to brain tumours using simultaneous synaptic Positron Emission Tomography (PET) and advanced Magnetic Resonance Imaging (MRI)
This PhD project is best suited for a student with a background in Physics or Engineering wishing to apply their quantitative skills to improve the understanding of the diseased brain. Read more
(MRC DTP) Quantitative biomarkers for the assessment of brain tumours
The use and benefits of gadolinium-based contrast agents in the diagnosis and assessment of pathologies such as brain tumours are well established. Read more
Last chance to apply
Leveraging radiomics to predict glioblastoma multiforme microenvironment and personalise treatment planning
Glioblastoma multiforme (GBM) is the most common primary brain tumour, with a dismal median survival. The tumour microenvironment (TME) is the microscopic-scale environment of tissue in which a tumour evolves and is a key component that controls GBM aggressiveness. Read more
Integrating Electrical Fields with Smart Nanoparticles and Biomimetic Hydrogels for Targeted Glioblastoma Therapy
Glioblastoma (GBM) is the most aggressive and lethal primary brain tumour in adults, with a high recurrence rate and limited treatment options. Read more
(MRC DTP) The impact of hearing impairment on neuropsychological functioning and quality of life following treatment for paediatric brain tumours
This is a unique opportunity for a candidate with a background in psychology to work on the important problem of quality of life after childhood cancer. Read more
Last chance to apply
Liquid biopsy biomarkers for early detection of paediatric brain tumours
Over the past four decades, significant advancements have been made in the treatment of childhood cancer, leading to a substantial increase in cure and survival rates. Read more
(MRC DTP CASE) Lipid Nanoparticles with Multivalent and Multi-Targeting Capabilities for the Treatment of Brain Cancer
Glioblastoma, an aggressive brain tumour with a dismal prognosis, presents a significant challenge due to the blood-brain barrier (BBB), which limits the efficacy of conventional chemotherapy. Read more
Vascularisation of tumour organoids for mechanistic and drug development
Gliomas such as are the most common form of brain tumour, a subset Glioblastoma (GBM) are devastating adult brain cancer with high rates of recurrence and treatment resistance. Read more
Cancer Neuroscience: Investigating the impact of non-CNS tumours on neuronal plasticity in the brain
To apply, please contact Dr Graham Sheridan at Graham.Sheridan@nottingham.ac.uk. Cancer is one of the leading causes of death worldwide, resulting in approximately 18 million new cases and 10 million deaths each year. Read more
Metabolic MRI of paediatric-type diffuse high grade glioma and its response to therapy in vivo
Paediatric-type diffuse high grade glioma (PDHGG) is a leading cause of tumour-related death in children and young adults, and novel therapeutic approaches are urgently needed (1). Read more
Identification of lung cancer patients at higher risk for brain metastasis using microfluidics
Applications are invited for a three-year PhD studentship. The studentship will start on 1st January 2025. . Project Description. Read more